241 related articles for article (PubMed ID: 32783943)
1. Acetylation Stabilizes Phosphoglycerate Dehydrogenase by Disrupting the Interaction of E3 Ligase RNF5 to Promote Breast Tumorigenesis.
Wang C; Wan X; Yu T; Huang Z; Shen C; Qi Q; Xiang S; Chen X; Arbely E; Ling ZQ; Liu CY; Yu W
Cell Rep; 2020 Aug; 32(6):108021. PubMed ID: 32783943
[TBL] [Abstract][Full Text] [Related]
2. Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression.
Liu J; Zhang C; Wu H; Sun XX; Li Y; Huang S; Yue X; Lu SE; Shen Z; Su X; White E; Haffty BG; Hu W; Feng Z
J Clin Invest; 2020 Jun; 130(6):3253-3269. PubMed ID: 32478681
[TBL] [Abstract][Full Text] [Related]
3. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.
Ma X; Li B; Liu J; Fu Y; Luo Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
[TBL] [Abstract][Full Text] [Related]
4. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.
Possemato R; Marks KM; Shaul YD; Pacold ME; Kim D; Birsoy K; Sethumadhavan S; Woo HK; Jang HG; Jha AK; Chen WW; Barrett FG; Stransky N; Tsun ZY; Cowley GS; Barretina J; Kalaany NY; Hsu PP; Ottina K; Chan AM; Yuan B; Garraway LA; Root DE; Mino-Kenudson M; Brachtel EF; Driggers EM; Sabatini DM
Nature; 2011 Aug; 476(7360):346-50. PubMed ID: 21760589
[TBL] [Abstract][Full Text] [Related]
5. Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth.
Chen J; Chung F; Yang G; Pu M; Gao H; Jiang W; Yin H; Capka V; Kasibhatla S; Laffitte B; Jaeger S; Pagliarini R; Chen Y; Zhou W
Oncotarget; 2013 Dec; 4(12):2502-11. PubMed ID: 24318446
[TBL] [Abstract][Full Text] [Related]
6. The NAD
Murphy JP; Giacomantonio MA; Paulo JA; Everley RA; Kennedy BE; Pathak GP; Clements DR; Kim Y; Dai C; Sharif T; Gygi SP; Gujar S
Cell Rep; 2018 Aug; 24(9):2381-2391.e5. PubMed ID: 30157431
[TBL] [Abstract][Full Text] [Related]
7. PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis.
Zhang B; Zheng A; Hydbring P; Ambroise G; Ouchida AT; Goiny M; Vakifahmetoglu-Norberg H; Norberg E
Cell Rep; 2017 Jun; 19(11):2289-2303. PubMed ID: 28614715
[TBL] [Abstract][Full Text] [Related]
8. 3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.
Li M; Wu C; Yang Y; Zheng M; Yu S; Wang J; Chen L; Li H
Cell Oncol (Dordr); 2021 Jun; 44(3):541-556. PubMed ID: 33735398
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer.
Bromberg KD; Kluger HM; Delaunay A; Abbas S; DiVito KA; Krajewski S; Ronai Z
Cancer Res; 2007 Sep; 67(17):8172-9. PubMed ID: 17804730
[TBL] [Abstract][Full Text] [Related]
10. ASS1 inhibits triple-negative breast cancer by regulating PHGDH stability and de novo serine synthesis.
Luo W; Zou Z; Nie Y; Luo J; Ming Z; Hu X; Luo T; Ouyang M; Liu M; Tang H; Xie Y; Peng K; Chen L; Zhou J; Luo Z
Cell Death Dis; 2024 May; 15(5):319. PubMed ID: 38710705
[TBL] [Abstract][Full Text] [Related]
11. FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma.
Luo L; Wu X; Fan J; Dong L; Wang M; Zeng Y; Li S; Yang W; Jiang J; Wang K
Nat Commun; 2024 Jun; 15(1):4790. PubMed ID: 38839752
[TBL] [Abstract][Full Text] [Related]
12. Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies.
Jeon YJ; Khelifa S; Ratnikov B; Scott DA; Feng Y; Parisi F; Ruller C; Lau E; Kim H; Brill LM; Jiang T; Rimm DL; Cardiff RD; Mills GB; Smith JW; Osterman AL; Kluger Y; Ronai ZA
Cancer Cell; 2015 Mar; 27(3):354-69. PubMed ID: 25759021
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics Analysis of the Role of PHGDH in Colon Cancer.
Dai Z; Chen L; Pan K; Zhao X; Xu W; Du J; Xing C
Technol Cancer Res Treat; 2023; 22():15330338221145994. PubMed ID: 36707056
[No Abstract] [Full Text] [Related]
14. Prognostic significance of phosphoglycerate dehydrogenase in breast cancer.
Chandrika M; Chua PJ; Muniasamy U; Huang RYJ; Thike AA; Ng CT; Tan PH; Yip GW; Bay BH
Breast Cancer Res Treat; 2021 Apr; 186(3):655-665. PubMed ID: 33625616
[TBL] [Abstract][Full Text] [Related]
15. Newcastle Disease Virus V Protein Degrades Mitochondrial Antiviral Signaling Protein To Inhibit Host Type I Interferon Production via E3 Ubiquitin Ligase RNF5.
Sun Y; Zheng H; Yu S; Ding Y; Wu W; Mao X; Liao Y; Meng C; Ur Rehman Z; Tan L; Song C; Qiu X; Wu F; Ding C
J Virol; 2019 Sep; 93(18):. PubMed ID: 31270229
[TBL] [Abstract][Full Text] [Related]
16. The Role of ESRP1 in the Regulation of PHGDH in Estrogen Receptor-Positive Breast Cancer.
Gökmen-Polar Y; Gu Y; Polar A; Gu X; Badve SS
Lab Invest; 2023 Mar; 103(3):100002. PubMed ID: 36925195
[TBL] [Abstract][Full Text] [Related]
17. Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate.
Fan J; Teng X; Liu L; Mattaini KR; Looper RE; Vander Heiden MG; Rabinowitz JD
ACS Chem Biol; 2015 Feb; 10(2):510-6. PubMed ID: 25406093
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells.
Mullarky E; Xu J; Robin AD; Huggins DJ; Jennings A; Noguchi N; Olland A; Lakshminarasimhan D; Miller M; Tomita D; Michino M; Su T; Zhang G; Stamford AW; Meinke PT; Kargman S; Cantley LC
Bioorg Med Chem Lett; 2019 Sep; 29(17):2503-2510. PubMed ID: 31327531
[TBL] [Abstract][Full Text] [Related]
19. Cul4A-DDB1-mediated monoubiquitination of phosphoglycerate dehydrogenase promotes colorectal cancer metastasis via increased S-adenosylmethionine.
Zhang Y; Yu H; Zhang J; Gao H; Wang S; Li S; Wei P; Liang J; Yu G; Wang X; Li X; Li D; Yang W
J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720086
[TBL] [Abstract][Full Text] [Related]
20. E3 Ubiquitin Ligase HRD1 Promotes Lung Tumorigenesis by Promoting Sirtuin 2 Ubiquitination and Degradation.
Liu L; Yu L; Zeng C; Long H; Duan G; Yin G; Dai X; Lin Z
Mol Cell Biol; 2020 Mar; 40(7):. PubMed ID: 31932479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
